Your browser doesn't support javascript.
loading
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
Maisonnasse, Pauline; Aldon, Yoann; Marc, Aurélien; Marlin, Romain; Dereuddre-Bosquet, Nathalie; Kuzmina, Natalia A; Freyn, Alec W; Snitselaar, Jonne L; Gonçalves, Antonio; Caniels, Tom G; Burger, Judith A; Poniman, Meliawati; Bontjer, Ilja; Chesnais, Virginie; Diry, Ségolène; Iershov, Anton; Ronk, Adam J; Jangra, Sonia; Rathnasinghe, Raveen; Brouwer, Philip J M; Bijl, Tom P L; van Schooten, Jelle; Brinkkemper, Mitch; Liu, Hejun; Yuan, Meng; Mire, Chad E; van Breemen, Mariëlle J; Contreras, Vanessa; Naninck, Thibaut; Lemaître, Julien; Kahlaoui, Nidhal; Relouzat, Francis; Chapon, Catherine; Ho Tsong Fang, Raphaël; McDanal, Charlene; Osei-Twum, Mary; St-Amant, Natalie; Gagnon, Luc; Montefiori, David C; Wilson, Ian A; Ginoux, Eric; de Bree, Godelieve J; García-Sastre, Adolfo; Schotsaert, Michael; Coughlan, Lynda; Bukreyev, Alexander; van der Werf, Sylvie; Guedj, Jérémie; Sanders, Rogier W; van Gils, Marit J.
Afiliação
  • Maisonnasse P; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • Aldon Y; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Marc A; Université de Paris, INSERM, IAME, Paris, France.
  • Marlin R; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • Dereuddre-Bosquet N; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • Kuzmina NA; Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • Freyn AW; Galveston National Laboratory, Galveston, TX, USA.
  • Snitselaar JL; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gonçalves A; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Caniels TG; Université de Paris, INSERM, IAME, Paris, France.
  • Burger JA; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Poniman M; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Bontjer I; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Chesnais V; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Diry S; Life and Soft, Le Plessis-Robinson, France.
  • Iershov A; Life and Soft, Le Plessis-Robinson, France.
  • Ronk AJ; Life and Soft, Le Plessis-Robinson, France.
  • Jangra S; Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • Rathnasinghe R; Galveston National Laboratory, Galveston, TX, USA.
  • Brouwer PJM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bijl TPL; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • van Schooten J; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Brinkkemper M; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Liu H; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Yuan M; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Mire CE; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • van Breemen MJ; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Contreras V; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Naninck T; Galveston National Laboratory, Galveston, TX, USA.
  • Lemaître J; Department of Microbiology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • Kahlaoui N; Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • Relouzat F; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • Chapon C; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • Ho Tsong Fang R; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • McDanal C; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • Osei-Twum M; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • St-Amant N; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • Gagnon L; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.
  • Montefiori DC; Duke Human Vaccine Institute & Department of Surgery, Durham, NC, USA.
  • Wilson IA; Nexelis, Laval, Québec, Canada.
  • Ginoux E; Nexelis, Laval, Québec, Canada.
  • de Bree GJ; Nexelis, Laval, Québec, Canada.
  • García-Sastre A; Duke Human Vaccine Institute & Department of Surgery, Durham, NC, USA.
  • Schotsaert M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Coughlan L; Life and Soft, Le Plessis-Robinson, France.
  • Bukreyev A; Internal Medicine of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
  • van der Werf S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Guedj J; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sanders RW; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • van Gils MJ; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nat Commun ; 12(1): 6097, 2021 10 20.
Article em En | MEDLINE | ID: mdl-34671037
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Anticorpos Neutralizantes / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Anticorpos Neutralizantes / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França